![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A01K 67/027 | (2006.01) |
C07K 16/00 | (2006.01) | ||
C07K 16/46 | (2006.01) | ||
C12N 15/85 | (2006.01) | ||
C12N 15/90 | (2006.01) |
(11) | Patento numeris | 3622813 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 19207050.6 |
Europos patento paraiškos padavimo data | 2010-07-07 | |
(97) | Europos patento paraiškos paskelbimo data | 2020-03-18 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2021-02-17 |
(46) | Apibrėžties vertimo paskelbimo data |
(30) | Numeris | Data | Šalis |
0911846 | 2009-07-08 | GB | |
22396009 P | 2009-07-08 | US | |
0913102 | 2009-07-28 | GB | |
35566610 P | 2010-06-17 | US |
(72) |
BRADLEY, Allan, GB
LEE, E-Chiang, GB
LIANG, Qi, GB
WANG, Wei, GB
|
(73) |
Kymab Limited,
The Bennet Building (B930) Babraham Research Campus, Cambridge CB22 3AT,
GB
|
(54) | ANIMAL MODELS AND THERAPEUTIC MOLECULES |
ANIMAL MODELS AND THERAPEUTIC MOLECULES |